Acute Lymphocytic Leukemia (ALL) Diagnosis

Receiving an accurate acute lymphocytic leukemia (ALL) diagnosis, and identifying its sub-type is extremely important in determining the treatment for your ALL. Different sub-types of ALL respond to different drugs and treatment therapies.

If you were diagnosed at another health care center, and are coming to the Abramson Cancer Center for treatment or a second opinion, repeat diagnostic tests may be necessary. Penn utilizes the latest diagnostic imaging tools, tests and procedures to develop your personalized treatment plan.

ALL Diagnostic Tools

Abramson Cancer Center utilizes a variety of leading edge diagnostic tools and tests to diagnose acute lymphocytic leukemia (ALL).

Staging ALL

Staging ALL can help physicians at the Abramson Cancer Center create a treatment plan designed specifically for you.